{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:45:34Z","timestamp":1780397134721,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10RR026866-01"],"award-info":[{"award-number":["1S10RR026866-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0818-0745-UCB"],"award-info":[{"award-number":["TA-GT-0818-0745-UCB"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omtm.2021.05.009","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:35:25Z","timestamp":1622248525000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery"],"prefix":"10.1016","volume":"22","author":[{"given":"Emilia A.","family":"Zin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Morrison-Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Visel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervi","family":"Kuronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.05.009_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","article-title":"The neuronal ceroid-lipofuscinoses: From past to present","volume":"1762","author":"Haltia","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"10 Pt B","key":"10.1016\/j.omtm.2021.05.009_bib2","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10 Pt B","key":"10.1016\/j.omtm.2021.05.009_bib3","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.05.009_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2021.05.009_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/brain\/awz377","article-title":"Homozygous GRN mutations: New phenotypes and new insights into pathological and molecular mechanisms","volume":"143","author":"Huin","year":"2020","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2021.05.009_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jnc.13622","article-title":"Genetics of FTLD: Overview and what else we can expect from genetic studies","volume":"138","author":"Pottier","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtm.2021.05.009_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.009_bib8","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.1074\/jbc.R112.399170","article-title":"Progranulin: A proteolytically processed protein at the crossroads of inflammation and neurodegeneration","volume":"287","author":"Cenik","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.05.009_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","article-title":"Progranulin in neurodegenerative disease","volume":"37","author":"Petkau","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtm.2021.05.009_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.05.009_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-017-0196-6","article-title":"The lysosomal protein cathepsin L is a progranulin protease","volume":"12","author":"Lee","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2021.05.009_bib12","first-page":"969","article-title":"Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes","volume":"26","author":"Tanaka","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.05.009_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2005.12.006","article-title":"You say lipofuscin, we say ceroid: Defining autofluorescent storage material","volume":"27","author":"Seehafer","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.omtm.2021.05.009_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.05.009_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbr.2007.07.020","article-title":"Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene","volume":"185","author":"Kayasuga","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.omtm.2021.05.009_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nbd.2011.10.016","article-title":"Synaptic dysfunction in progranulin-deficient mice","volume":"45","author":"Petkau","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2021.05.009_bib17","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1172\/JCI63113","article-title":"Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury","volume":"122","author":"Martens","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.05.009_bib18","first-page":"6115","article-title":"Progranulin mutant mice exhibit accumulation of intraneuronal lipofuscin aggregates in the retina","volume":"54","author":"Hafler","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2021.05.009_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2014.09.023","article-title":"Progressive retinal degeneration and accumulation of autofluorescent lipopigments in progranulin deficient mice","volume":"1588","author":"Hafler","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2021.05.009_bib20","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20140214","article-title":"Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD","volume":"211","author":"Ward","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2021.05.009_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2020.09.033","article-title":"AAV9 gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-Batten disease","volume":"29","author":"Johnson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","article-title":"Prevention of photoreceptor cell loss in a Cln6nclf mouse model of Batten disease requires CLN6 gene transfer to bipolar cells","volume":"26","author":"Kleine Holthaus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2021.05.009_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T\u00a0cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib25","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.05.009_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mt.2014.181","article-title":"The expression pattern of systemically injected AAV9 in the developing mouse retina is determined by age","volume":"23","author":"Byrne","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib27","doi-asserted-by":"crossref","first-page":"aah5642","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.05.009_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gt.2011.163","article-title":"Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9","volume":"19","author":"Dalkara","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib29","doi-asserted-by":"crossref","first-page":"e145936","DOI":"10.1172\/jci.insight.145936","article-title":"Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome","volume":"6","author":"Zhao","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2021.05.009_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/gt.2011.200","article-title":"AAV-based neonatal gene therapy for hemophilia A: Long-term correction and avoidance of immune responses in mice","volume":"19","author":"Hu","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.05.009_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2017.05.003","article-title":"Involvement of progranulin in modulating neuroinflammatory responses but not neurogenesis in the hippocampus of aged mice","volume":"95","author":"Ma","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.omtm.2021.05.009_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","article-title":"Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice","volume":"231","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2021.05.009_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2013.06.049","article-title":"Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice","volume":"250","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2021.05.009_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-62703-080-9_25","article-title":"Adeno-associated viral vectors for gene therapy of inherited retinal degenerations","volume":"935","author":"Flannery","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2021.05.009_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:38Z","timestamp":1762421258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S2329050121000930"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.05.009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.24.432570","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}